Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
复制标题
DOI：
10.1371/journal.pone.0119543
复制
发表时间：
2015
期刊：
影响因子：
3.7
通讯作者：
Zhou XJ
中科院分区：
文献类型：
--
作者：
Ye T;Zhen J;Du Y;Zhou JK;Peng A;Vaziri ND;Mohan C;Xu Y;Zhou XJ
Crescentic glomerulonephritis (GN) is the most severe form of GN and is associated with significant morbidity and mortality despite aggressive immunotherapy with steroids, cytotoxic drugs, and plasmapheresis. We examined the therapeutic efficacy of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG, 50 mg/kg BW/day x3weeks), a potent anti-inflammatory and anti-oxidant agent, on experimental crescentic GN induced in 129/svJ mice by administration of rabbit anti-mouse glomerular basement membrane sera. Routine histology and key molecules involved in inflammatory and redox signaling were studied. EGCG treatment significantly reduced mortality, decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. The improvements in renal function and histology were accompanied by the restoration of Nrf2 signaling (which was impaired in vehicle-treated mice) as shown by increased nuclear translocation of Nrf2 and cytoplasmic glutamate cysteine ligase catalytic subunit, glutamate cysteine ligase modifier subunit, and glutathione peroxidase. EGCG-treated mice also showed reduction in p-Akt, p-JNK, p-ERK1/2 and p-P38 as well as restoration of PPARγ and SIRT1 levels. Lower dose of EGCG (25 mg/kg BW/day x2 weeks) treatment also significantly decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. Thus, our data illustrate the efficacy of EGCG in reversing the progression of crescentic GN in mice by targeting multiple signaling and inflammatory pathways as well as countering oxidative stress.
登录
查看更多内容
DOI：
10.1164/rccm.200907-1047oc
发表时间：
2010-07-01
影响因子：
24.7
作者：
Cho, Hye-Youn;Gladwell, Wesley;Kleeberger, Steven R.
通讯作者：
Kleeberger, Steven R.
DOI：
10.1152/ajprenal.00583.2009
发表时间：
2010-08-01
影响因子：
4.2
作者：
Lu, Hua;Zhen, Junhui;Zhou, Xin J.
通讯作者：
Zhou, Xin J.
影响因子：
8
作者：
Afaq, F;Adhami, VM;Mukhtar, H
通讯作者：
Mukhtar, H
DOI：
10.1006/bbrc.1997.6943
发表时间：
1997-07-18
影响因子：
3.1
作者：
Itoh, K;Chiba, T;Nabeshima, Y
通讯作者：
Nabeshima, Y
DOI：
10.1056/nejmoa0910500
发表时间：
2010-07-22
期刊：
The New England journal of medicine
影响因子：
--
作者：
Pedchenko V;Bondar O;Fogo AB;Vanacore R;Voziyan P;Kitching AR;Wieslander J;Kashtan C;Borza DB;Neilson EG;Wilson CB;Hudson BG
通讯作者：
Hudson BG